Arbutus Biopharma Corporation
Market Cap
$838.53M
P/E Ratio
-18.96
EPS
$-0.23
Dividend Yield
0.00%
52-Week Range
$2.71 — $5.10
Volume
1.32M
Avg Volume
2.10M
Beta
0.74
P/E (TTM)
-18.96
Forward P/E
—
PEG Ratio
-1.00
P/S (TTM)
62.15
P/B (TTM)
11.70
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.50%
ROA (TTM)
-0.43%
ROIC
—
Gross Margin
-0.22%
Operating Margin
-3.79%
Net Margin
—
Debt/Equity
0.01
Current Ratio
18.80
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.18%
EPS Growth (5Y)
+0.28%
Sales Growth (3Y)
+0.45%
Sales Growth (5Y)
+0.42%
EPS Est (This Year)
$-0.16
EPS Est (Next Year)
$-0.05
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.49
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
192.32M
Float
150.24M
Free Float %
78.12%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2007-07-26
Employees
44
CEO
Lindsay Androski
Index Membership
—
Website
https://www.arbutusbio.com
Arbutus Biopharma Corporation (ABUS) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $838.53M, a P/E ratio of -18.96, ABUS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ABUS against other stocks using dozens of fundamental and technical filters.
Arbutus Biopharma Corporation (ABUS) has a trailing twelve-month (TTM) P/E ratio of -18.96. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Arbutus Biopharma Corporation (ABUS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Arbutus Biopharma Corporation (ABUS) has a market capitalization of $838.53 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.